Home Telemonitoring In Patients After Myocardial Infarction

NACompletedINTERVENTIONAL
Enrollment

195

Participants

Timeline

Start Date

October 14, 2020

Primary Completion Date

May 2, 2024

Study Completion Date

May 2, 2024

Conditions
Myocardial InfarctionHeart Attack
Interventions
DEVICE

SmartHeart Device

A body-worn device that allows an individual to immediately transmit a 12-lead ECG from anywhere and anytime, using a smartphone application to a physician's office, hospital or monitoring center where designated on-call staff interpret the ECG and make recommendations.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04664881 - Home Telemonitoring In Patients After Myocardial Infarction | Biotech Hunter | Biotech Hunter